For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220318:nRSR2086Fa&default-theme=true
RNS Number : 2086F Agronomics Limited 18 March 2022
18th March 2022
Agronomics Limited (https://agronomics.im/)
("Agronomics" or the "Company")
Agronomics Joins the Alternative Proteins Association
Agronomics, the leading listed investment company focused on cellular
agriculture, is pleased to announce it has joined the Alternative Proteins
Association ("APA") as a founding member following its launch on the 15(th) of
March at the Houses of Parliament. The APA is a trade association and
non-profit organisation that exists to fuel collaboration across the value
chain. It will be a place for entrepreneurs, policymakers, researchers,
thought-leaders and investors to navigate the UK regulatory process and
advocate for public policy to support the development of the rapidly evolving
UK alternative protein industry.
Jim Mellon, executive director of Agronomics and advisory board member of the
APA commented:-
"Agronomics is honoured to be joining the APA as a founding member. We believe
that the UK has a huge opportunity to show leadership in the burgeoning
alternative proteins industry, with the opportunity to shape its own
regulatory framework. The launch of the APA will serve to enhance
collaboration within the alternative protein ecosystem and directly involve
policymakers in the conversation, ultimately accelerating the timeline for
cellular agriculture products to reach the UK market"
More information about The APA can be found at
https://www.alternativeproteinsassociation.com/
(https://www.alternativeproteinsassociation.com/) .
About Alternative Proteins Association
(https://www.alternativeproteinsassociation.com/overview)
The Alternative Proteins Association (APA) is the largest association of its
kind in Europe, designed to promote the value of alternative proteins in the
UK. The APA aims to tackle the challenges presented by food insecurity,
climate change, the cost of living and intensive farming by helping the UK
become a world leader in alternative proteins and inspiring collective action.
Taking inspiration from the United Nations Sustainable Development Goals and
COVID-19 vaccination programmes, the APA is focused on simple but ambitious
goals for the UK and alternative proteins industry which if achieved by 2030
will improve life for us all, for generations to come. Launched by Jeremy
Coller and The Lord Sarfraz in March 2022, the Alternative Proteins
Association is the largest association of its kind in Europe.
About Agronomics (https://agronomics.im/)
Agronomics is a leading listed alternative proteins company with a focus on
cellular agriculture and cultivated meat. The Company has established a
portfolio of 20 companies at the Pre-Seed to Series C stage in this rapidly
advancing sector. It seeks to secure minority stakes in companies owning
technologies with defensible intellectual property that offer new ways of
producing food and materials with a focus on products historically derived
from animals. These technologies are driving a major disruption in
agriculture, offering solutions to improve sustainability, as well as
addressing human health, animal welfare and environmental damage. This
disruption will decouple supply chains from the environment and animals, as
well as being fundamental to feeding the world's expanding population. A full
list of Agronomics' portfolio companies is available
at https://agronomics.im/
(https://clicktime.symantec.com/368cVqxx3R6vTFuHpf6MSE66Gi?u=https%3A%2F%2Fagronomics.im%2F)
.
About Cellular Agriculture
Cellular Agriculture is the production of agriculture products directly from
cells, as opposed to raising an animal for slaughter, or growing crops. This
encompasses cell culture to produce cultivated meat and materials, and
fermentation processes that harness a combination of molecular biology,
synthetic biology, tissue engineering and biotechnology to massively simplify
production methods in a sustainable manner.
Over the coming decades, the source of the world's food supply traditionally
derived from conventional agriculture is going to change dramatically. We have
already witnessed the first wave of this shift with the consumer adoption of
plant-based alternative proteins but today, we are on the cusp of an even
bigger wave of change. This is being facilitated by advances in cellular
agriculture. This change is necessary, given scientists claims that if we
maintain existing animal protein consumption patterns, then we will not meet
the Paris Agreement's goal of limiting warming to 1.5℃
AT Kearney, a global consultancy firm, projects that cultivated meat's market
share will reach 35% by 2040. This combined with the Good Food
Institute's estimate that a US$ 1.8 trillion investment will be required in
order to produce just 10% of the world's protein using this technology, means
that we are on the cusp of a multi-decade flow of capital to build out
manufacturing facilities. Funding in the field of cellular agriculture is
accelerating, however still less than US$ 2 billion has been invested
worldwide since the industry's inception in 2016.
For further information please contact:
Agronomics Beaumont Cenkos Peterhouse Capital
Limited Cornish Limited Securities Plc Limited TB Cardew
The Company Nomad Joint Broker Joint Broker Public Relations
Richard Reed Roland Cornish Giles Balleny Lucy Williams Ed Orlebar
Denham Eke James Biddle Michael Johnson Charles Goodfellow Joe McGregor
+44 (0) 1624 639396 +44 (0) 207 628 3396 +44 (0) 207 397 8900 +44 (0) 207 469 0936 +44 (0) 20 7930 0777
info@agronomics.im (mailto:info@agronomics.im) +44 (0) 7738 724 630
agronomics@tbcardew.com (mailto:agronomics@tbcardew.com)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCKDLFFLXLZBBK